![Seeking Alpha](https://s3.amazonaws.com/weyland.altmetric.com/news_sources/logos/000/001/665/normal/Screen_Shot_2016-01-26_at_13.35.16.png?1453815336)
Evelo Biosciences: May Be Worth A Small, Highly Speculative Long Position Considering Upcoming Psoriasis Phase 2 Results
Seeking Alpha,
Summary Following recent cash raise, EVLO has enough (barely) cash to the next catalyst, phase 2 readout in psoriasis.